EMERALD ADVISERS, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 157 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2016$69,000
-97.7%
12,307
-97.8%
0.00%
-97.9%
Q2 2016$3,028,000
-26.2%
551,521
-0.2%
0.15%
-27.0%
Q1 2016$4,101,000
-14.7%
552,751
-4.5%
0.20%
-11.9%
Q4 2015$4,810,000
+8.1%
578,805
+17.2%
0.23%
-2.2%
Q3 2015$4,451,000
-26.2%
493,966
-1.8%
0.23%
-19.4%
Q2 2015$6,033,000
+79.3%
502,770
+37.8%
0.29%
+70.4%
Q1 2015$3,364,000
+151.8%
364,808
+38.4%
0.17%
+138.0%
Q4 2014$1,336,000
+18985.7%
263,508
+14872.0%
0.07%
Q2 2014$7,0001,7600.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2015
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders